Public Profile

Ondrugdelivery

Ondrugdelivery, a leading name in the pharmaceutical and biotechnology sectors, is headquartered in Great Britain. Founded in 2000, the company has established itself as a pivotal player in drug delivery systems, focusing on innovative solutions that enhance therapeutic efficacy and patient compliance. With a strong presence in Europe and North America, Ondrugdelivery offers a range of services, including drug formulation, delivery device development, and regulatory support. Their unique approach combines cutting-edge technology with extensive industry expertise, setting them apart in a competitive market. Recognised for their commitment to quality and innovation, Ondrugdelivery has achieved significant milestones, including partnerships with major pharmaceutical companies and contributions to groundbreaking research. Their dedication to advancing drug delivery methods continues to solidify their position as a trusted leader in the industry.

DitchCarbon Score

How does Ondrugdelivery's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Media Production industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

25

Industry Benchmark

Ondrugdelivery's score of 23 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

63%

Let us know if this data was useful to you

Ondrugdelivery's reported carbon emissions

In 2022, Ondrugdelivery reported emissions related to their operations, specifically noting that the carbon footprint per dose of their dry powder inhalers (DPIs) is approximately 0.0095 kg CO2e. However, detailed total emissions data, including Scope 1, 2, and 3 emissions, has not been disclosed. Currently, Ondrugdelivery has not set specific reduction targets or initiatives, nor have they made any formal climate pledges. This lack of defined commitments places them in a broader industry context where many organisations are increasingly focusing on sustainability and carbon reduction strategies. As Ondrugdelivery continues to operate within the pharmaceutical sector, it is essential for them to consider establishing measurable climate commitments to align with global sustainability goals and enhance their environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ondrugdelivery's primary industry is Printed matter and recorded media (22), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ondrugdelivery is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ondrugdelivery is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers